Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV – Research Report), Apollo Medical Holdings (AMEH – Research Report) and Twist Bioscience (TWST – Research Report).
Barclays analyst Carter Gould maintained a Hold rating on AbbVie on August 5 and set a price target of $160.00. The company’s shares closed last Friday at $138.04.
According to TipRanks.com, Gould is a 3-star analyst with an average return of
Currently, the analyst consensus on AbbVie is a Moderate Buy with an average price target of $159.38, which is a 14.6% upside from current levels. In a report issued on August 1, Atlantic Equities also downgraded the stock to Hold with a $162.00 price target.
Apollo Medical Holdings (AMEH)
Barclays analyst Sarah James maintained a Hold rating on Apollo Medical Holdings on August 5 and set a price target of $57.00. The company’s shares closed last Friday at $54.40.
According to TipRanks.com, James is a 5-star analyst with an average return of
Apollo Medical Holdings has an analyst consensus of Hold, with a price target consensus of $57.00.
Twist Bioscience (TWST)
Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience on August 5 and set a price target of $55.00. The company’s shares closed last Friday at $52.77.
According to TipRanks.com, Sergott is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Twist Bioscience with a $55.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABBV:
- Analysts Conflicted on These Consumer Goods Names: Burlington Stores (BURL), Kellogg (K) and Edgewell Personal Care (EPC)
- Analysts Conflicted on These Technology Names: Epam Systems (EPAM), Twilio (TWLO) and Open Text (OTEX)
- Barclays Reaffirms Their Buy Rating on Casa Systems (CASA)
- Barclays Sticks to Its Hold Rating for Integral Ad Science (IAS)
- Barclays Keeps Their Hold Rating on American Eagle (AEO)